[ad_1]


MUMBAI (Reuters) – Nearly 90% of people in India’s financial capital, Mumbai, are estimated to have COVID-19 antibodies, according to the civic body survey released on Friday.

8.674 adult subjects participated in the fifth blood serum test, also known as a sero-survey. It was conducted from August to September. Nearly 65% were immunized.

Also, the survey revealed that more women had COVID-19 antibody than their male counterparts (88.07% vs 88.29%).

According to the Brihanmumbai Metropolitan Corporation (BMC), the sero-prevalence of individuals who have received one or more doses COVID-19 vaccines was much higher than that in unvaccinated persons.

According to the report, “The seroprevalence of those who have received COVID-19 vaccine is significantly higher than that of their unvaccinated peers.”

Mumbai, India’s financial capital and a populated city won praises for its ability to tackle the second pandemic wave better than any other major metropolis.

This report comes as there are still concerns about the emergence of another wave. India recorded 34,403 additional COVID-19 case reports on Friday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are only given by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]